Last reviewed · How we verify
NCT05264246
Evaluation of an Anti-Shivering Protocol Cardiac Arrest
trial in Cardiac Arrest in 165 participants. Terminated before completion.
9 September 2024
Quick facts
| Lead sponsor | Methodist Health System |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 165 |
| Start date | 15 September 2021 |
| Primary completion | 9 September 2024 |
| Estimated completion | 9 September 2024 |
| Sites | 1 location across United States |
Conditions studied
- Cardiac Arrest — all drugs for Cardiac Arrest →
Sponsor
Methodist Health System — full company profile →
Who can join
18 and older, any sex, with Cardiac Arrest. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This will be a single center, retrospective, before-and-after, chart review of all patients undergoing TTM between June 1, 2017 and May 31, 2021 at MDMC. Initiation of the new TTM protocol occurred on April 22, 2019.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Targeted Temperature Management in Cardiac Arrest: An Updated Narrative Review.
Belur AD, Sedhai YR, Truesdell AG, Khanna AK, et al · · 2023 · cited 12× · PMID 36527676 · DOI 10.1007/s40119-022-00292-4
Verify or expand the search:
- PubMed search for NCT05264246
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cardiac Arrest
Currently open trials in the same condition.
- NCT07239206 — Serious Game for Improving Targeted Temperature Management Knowledge and Situational Awareness in Critical Care Nurses · NA · recruiting
- NCT06780722 — Study of the Occurrence of Cardiocirculatory Arrest as a Function of the Level of Hypoxemia During a Maastricht 3 Proced · recruiting
- NCT06405581 — The Impact of Frailty on Cardiopulmonary Resuscitation Adverse Outcomes in Patients Requiring Code Blue Activation · recruiting
- NCT06511999 — Continuous Jugular Venous Oxygen Saturation (SjO2) Measurement After Cardiac Arrest · recruiting
- NCT07113769 — Plasma Biomarkers and Platelet Morphology of Extracorporeal CardioPulmonary Resuscitation · recruiting
Other Methodist Health System trials
Trials by the same sponsor.
- NCT06698302 — Validation of COMPAT-SF Spanish Translation · recruiting
- NCT04090034 — Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors · recruiting
- NCT07486362 — Evaluation of Emergency Medicine Pharmacist Impact on Blood Culture Review Following Emergency Department Discharge · recruiting
- NCT06222424 — Emergency Medicine Pharmacist Prescriptive Authority for Resolution of Outpatient Prescription Issues · NA · completed
- NCT07492758 — Management of Extremity Injuries Registry · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05264246 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Methodist Health System
- Last refreshed: 23 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05264246.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing